MedPath

Painless Subconjunctival Antibiotic and Antifungal Injection in Corneal Ulcer Patients

Not Applicable
Terminated
Conditions
Corneal Ulcer
Interventions
Procedure: NSS/Lidocaine
Procedure: Lidocaine/NSS
Registration Number
NCT00789646
Lead Sponsor
Mahidol University
Brief Summary

The propose of this study is to determine the efficacy of 2% xylocaine in reducing pain due to subconjunctival antibiotic and antifungal injection.

Detailed Description

Not available

Recruitment & Eligibility

Status
TERMINATED
Sex
All
Target Recruitment
10
Inclusion Criteria
  • The corneal ulcer patients who are diagnosed by ophthalmologist and have 2 of 3 in these following features.

    1. corneal epithelial defect with stromal infiltration
    2. reaction in anterior chamber
    3. positive for bacteria or fungus
  • The patients have to receive subconjunctival antibiotic injection twice at least.

  • The patients must be informed consent.

Exclusion Criteria
  • The patients who have history of allergy of local anesthetics, antibiotics or antifungal drugs.
  • The patients who administered NSAIDs or weak opioids within 24 hours prior to subconjunctival antibiotic/antifungal injection.
  • Unable to cooperate with the treatment.
  • Pregnant women

Study & Design

Study Type
INTERVENTIONAL
Study Design
CROSSOVER
Arm && Interventions
GroupInterventionDescription
NSS/LidocaineNSS/LidocaineFirst injection: Normal saline Second injection: 2% Lidocaine without adrenaline
Lidocaine/NSSLidocaine/NSSFirst injection: 2% Lidocaine without adrenaline Second injection: Normal saline
Primary Outcome Measures
NameTimeMethod
Numeric rating scaleimmediately after injection
Secondary Outcome Measures
NameTimeMethod
Side effects24 hours after injection
© Copyright 2025. All Rights Reserved by MedPath